These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26679983)

  • 1. Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia.
    Cassoli JS; Guest PC; Santana AG; Martins-de-Souza D
    Proteomics Clin Appl; 2016 Apr; 10(4):442-55. PubMed ID: 26679983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome effects of antipsychotic drugs: Learning from preclinical models.
    Carboni L; Domenici E
    Proteomics Clin Appl; 2016 Apr; 10(4):430-41. PubMed ID: 26548651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
    Pillai A; Parikh V; Terry AV; Mahadik SP
    J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M; Sapin C; Beillat M; Robinson P; Treur M
    J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
    Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA
    Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of clozapine versus other antipsychotics on clinical outcome and dopamine release in the brain.
    Advokat C
    Essent Psychopharmacol; 2005; 6(2):73-90. PubMed ID: 15765792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications.
    Ji B; La Y; Gao L; Zhu H; Tian N; Zhang M; Yang Y; Zhao X; Tang R; Ma G; Zhou J; Meng J; Ma J; Zhang Z; Li H; Feng G; Wang Y; He L; Wan C
    J Proteome Res; 2009 Jul; 8(7):3633-41. PubMed ID: 19441803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database.
    Kim S; Zavitsanou K; Gurguis G; Webster MJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):683-94. PubMed ID: 22356822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists.
    Fagiolini A; Alfonsi E; Amodeo G; Cenci M; Di Lella M; Farinella F; Ferraiuolo F; Fraguas D; Loparco N; Gutierrez-Rojas L; Mignone ML; Pataracchia G; Pillai G; Russo F; Sanchez-Gistau V; Spinogatti F; Toscano M; Villari V; De Filippis S
    Expert Opin Drug Saf; 2016; 15(4):449-55. PubMed ID: 26886162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atypical pharmacologic characteristics of an antipsychotic drug: clozapine].
    Gosselin O; Ribeyre JM; Kahn JP
    Encephale; 1997 Sep; 23 Spec No 4():2-6. PubMed ID: 9417400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia.
    Seabra G; de Almeida V; Reis-de-Oliveira G; Crunfli F; Antunes ASLM; Martins-de-Souza D
    Sci Rep; 2020 Jul; 10(1):12655. PubMed ID: 32724114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing treatment with clozapine.
    Conley RR
    J Clin Psychiatry; 1998; 59 Suppl 3():44-8. PubMed ID: 9541338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
    Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM
    J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
    Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM
    Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia.
    Rizig MA; McQuillin A; Ng A; Robinson M; Harrison A; Zvelebil M; Hunt SP; Gurling HM
    J Psychopharmacol; 2012 Sep; 26(9):1218-30. PubMed ID: 22767372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus.
    Schubert KO; Föcking M; Wynne K; Cotter DR
    Proteomics; 2016 Feb; 16(3):532-8. PubMed ID: 26607048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.